Joseph Walter Vazzano

Joseph Walter Vazzano is a declared insider at 2 companies (finance chief); the most frequent names are Abeona Therapeutics Inc. and Avenue Therapeutics, Inc. We count 44 filings; the first trade dates from 28 June 2018 and the latest from 29 September 2026.

Market trades split into 8 purchases (€71k) and 17 sales (€969k). Netting one side against the other leaves €899k of net selling. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The rest of the record consists of 18 share grants. In 2026 alone, the filings show no purchases and 8 sales.

Half of the purchases are above €9,939 and half below. Clusters matter here: 7 out of 7 purchases overlapped with buying by a colleague within 30 days. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase.

The newest entry dates from 29 September 2026: an open-market sale of €42k, in Abeona Therapeutics Inc. The clock since the last published purchase (26 April 2024) now reads 911 days. Filings reach the SEC (Form 4) feed a median of 1 day after the trade. The legal deadline for a Form 4 is two business days after the transaction. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.